ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Post-operative complications"

  • 2016 American Transplant Congress

    “Day 2 Discharge” After Kidney Transplantation: Complications, Health Care Utilization, and Long-Term Clinical Outcomes.

    A. Mathur, N. Katariya, A. Welu, J. Chang, R. Heilman, A. Singer, H. Khamash, H. Chakkera, W. Hewitt, D. Haakinson, M. Maningo-Salinas, E. Oakley, A. Moss, K. Reddy.

    Transplant Center, Mayo Clinic, Phoenix.

    Background: Reducing kidney transplant length of stay is a priority for many stakeholders. We aimed to determine whether very early discharge – on or before…
  • 2016 American Transplant Congress

    Hospitalizations for Cardiovascular Disease After Kidney Transplantation: The Role of Facility Characteristics on Outcomes and Costs.

    A. Mathur, Y.-H. Chang, D. Steidley, N. Katariya, A. Singer, W. Hewitt, K. Reddy, N. Wasif, D. Etzioni, A. Moss.

    Mayo Clinic, Phoenix, AZ.

    Background: Long term outcomes are in jeopardy when kidney transplant recipients are hospitalized with cardiovascular disease (CVD). We sought to understand hospital predictors of inpatient…
  • 2016 American Transplant Congress

    Effect of Telehealth Monitoring on Early Hospital Readmission After Renal Transplantation.

    K. Noon,1 N. Sarabu,1 J. Augustine,1 D. Hricik,1 B. Deleva,1 K. Woodside,2 M. Aeder,1 J. Foote,1 A. Bruno,1 K. Walsh,1 M. Johnston,1 V. Humphreville,1 E. Sanchez.1

    1University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH; 2University of Michigan, Ann Arbor, MI.

    Introduction: Early hospital readmission (EHR) is an important quality metric of hospitals' performance. Kidney transplant surgery has a high EHR rate. It is not known…
  • 2016 American Transplant Congress

    A Nationwide Analysis of Reoperation After kidney Transplant.

    Z. Moghadamyeghaneh, M. Alameddine, G. Burke, G. Ciancio, L. Chen.

    Surgery, Division of Transplant Surgery, University of Miami School of Medicine, Miami, FL.

    ObjectivesWe aim to report the rate and short-term outcomes of patients undergoing reoperation following kidney transplant in the United States.MethodsThe NIS database was used to…
  • 2016 American Transplant Congress

    Anti-Thymocyte Globulin Induction Does Not Increase the Risk of Thrombotic Events in Kidney Transplantation: A Matched Case-Control Study.

    J. Iuppa,1 M. Dokus,2 E. Venniro,3 A. Patel,2 A. Danzig,4 J. Hahn,1 R. Kashyap,2 M. Orloff,2 J. Taylor.3

    1Department of Pharmacy, University of Rochester, Rochester, NY; 2Department of Surgery, Division of Transplantation and Hepatobiliary Surgery, University of Rochester, Rochester, NY; 3Department of Medicine, Division of Nephrology, University of Rochester, Rochester, NY; 4School of Medicine and Dentistry, University of Rochester, Rochester, NY.

    Background: Anti-thymocyte globulin (ATG) is the most commonly used induction agent in kidney transplantation (KTx). To date, case reports and in vitro analyses have suggested…
  • 2016 American Transplant Congress

    Never Events and Hospital Acquired Conditions After Kidney Transplant.

    Z. Moghadamyeghaneh, M. Alameddine, G. Burke, G. Ciancio, L. Chen.

    Surgery, Division of Transplant Surgery, University of Miami School of Medicine, Miami, FL.

    Introduction: Never Events (NE) and Hospital Acquired Conditions (HAC) after surgery have been designated as quality metrics in health care by the centers for Medicare…
  • 2016 American Transplant Congress

    Biliary Epithelial Damage, Regenerative Capacity and Local Immune Response After Cold Storage of DBD Livers Determine Biliary Complications After Liver Transplantation.

    S. Brunner, H. Junger, H. Schlitt, S. Fichtner-Feigl.

    Department of Surgery, University Medical Center Regensburg, Regensburg, Germany.

    Background: The aim of this study was to examine the development and molecular mechanisms of bile duct (BD) damage between organ retrieval and transplantation and…
  • 2016 American Transplant Congress

    Improving Donor Comfort: Perioperative Dexamethasone Decreases Nausea, Vomiting, and Pain After Laparoscopic Donor Nephrectomy.

    S. Yamanaga,1,2 A. Posselt,1 C. Freise,1 S.-M. Kang.1

    1Division of Transplant Surgery, Department of Surgery, University of California-San Francisco, San Francisco, CA; 2Department of General Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.

    Introduction: Postoperative nausea and vomiting (PONV) and pain are common adverse events after laparoscopic surgery. Perioperative dexamethasone (8-10mg) has been reported to decrease PONV and…
  • 2016 American Transplant Congress

    Circulating miR-215, miR-let-7c miR-154, miR-193a, NR_036506.1 and NR_027669.1 as Biomarkers Predict Fungal Infection in Post-Transplanted Recipients.

    A. Yang, Z. Guo, W. Ju, C. Zhang, Z. Li, X. Yuan, Q. Zhao, H. Ye, Y. Liao, X. Zhu, X. He.

    Organ Transplantation Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aims: The incidence of fungal infection in post-transplanted patients is 13%-17%, which seriously effecting perioperative survival and increasing their economic burden. We wanted to find…
  • 2016 American Transplant Congress

    Immediate Introduction of Everolimus Does Not Affect Wound Healing and Delayed Graft Function in Kidney Transplant Recipients: 3-Months Results from NEVERWOUND Study.

    M. Carmellini,1 P. Todeschini,2 A. Secchi,3 S. Sandrini,4 E. Minetti,5 L. Furian,6 G. Spagnoletti,7 F. Pisani,8 G. Piredda,9 G. Cappelli,10 G. Tisone.11

    1AOU Senese, Siena, Italy; 2AOP S.Orsola-Malpighi, Bologna, Italy; 3Osp San Raffaele IRCCS, Milano, Italy; 4AO Spedali Civili, Brescia, Italy; 5AOU Careggi, Firenze, Italy; 6AOU di Padova, Padova, Italy; 7PU A.Gemelli, Roma, Italy; 8POU S.Salvatore, L'Aquila, Italy; 9AO G.Brotzu, Cagliari, Italy; 10AOUP di Modena, Modena, Italy; 11Fondazione PU Tor Vergata, Roma, Italy.

    The NEVERWOUND study was designed to evaluate the impact of immediate vs. delayed introduction of everolimus (EVR) on wound healing complications (WHC) and delayed graft…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 28
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences